Both in Biotechnology
Candel Therapeutics vs 4D Molecular Therapeutics
Over the past year CADL returned +76.4% and FDMT returned +14.2%; their daily moves had a correlation of 0.47.
CADL +76.4% FDMT +14.2%Growth of $1, one year, split-adjusted
| Metric | CADL | FDMT |
|---|---|---|
| Price | $9.05 | $12.28 |
| Market cap | $692.5M | $678.4M |
| Today | +2.61% | +2.76% |
| 1 month | −8.3% | −2.2% |
| 6 months | +18.6% | +17.9% |
| Year to date | +60.2% | +63.7% |
| 1 year | +73.4% | +9.4% |
| Revenue growth (YoY) | — | +25106.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −1929.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.4× |
| Net cash | $153.7M | $341.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 76.2% |
| Short % of float | 21.5% | 21.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).